HOME BANCSHARES, INC.

HOMB

CIK 0001331520 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$324M
↑+0.3% +$917Kvs FY2024 (Q4)
Operating Income
$283M
↑+0.2% +$448Kvs FY2024 (Q4)
Net Income
$118M
↑+17.6% +$18Mvs FY2024 (Q4)
Gross Profit
$324M
↑+0.3% +$917Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
12/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    52D/E 0.96 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.06x (1.0+ = capital-efficient)
  • Growth
    18Revenue YoY +0.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project HOMB's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -1.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$26.63
Total enterprise IV
$5.26B
Diluted shares
0.20B
Terminal PV
$3.71B (70% of total)
Year-5 FCF
$437M
YearProjected FCFDiscounted PV
+1$388M$353M
+2$400M$331M
+3$412M$310M
+4$424M$290M
+5$437M$271M
Terminal$5.97B$3.71B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$22M
investment in PP&E
Dividends paid (TTM)
$159M
cash returned to holders
Stock buybacks (TTM)
$82M
share count reduction
Stock-based comp (TTM)
$11M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$22.88B
everything owned
Total liabilities
$18.59B
everything owed
Stockholders' equity
$4.30B
shareholder claim
Net debt
$603M
LT debt minus cash

Recent performance · 63 quarters

Revenue↑+0.3% +$917K
$324M
Net Income↑+16.4% +$50M
$352M
Free Cash Flow↑+38.4% +$23M
$84M

Drill down